JP2010538609A - 腫瘍グレード分類と癌の予後診断 - Google Patents

腫瘍グレード分類と癌の予後診断 Download PDF

Info

Publication number
JP2010538609A
JP2010538609A JP2010524215A JP2010524215A JP2010538609A JP 2010538609 A JP2010538609 A JP 2010538609A JP 2010524215 A JP2010524215 A JP 2010524215A JP 2010524215 A JP2010524215 A JP 2010524215A JP 2010538609 A JP2010538609 A JP 2010538609A
Authority
JP
Japan
Prior art keywords
cancer
grade
mgi
subject
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010524215A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010538609A5 (enExample
Inventor
ジー． アーランダー，マーク
マ，シャオ−ジュン
スグロイ，デニス
Original Assignee
バイオセラノスティクス，インコーポレイティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオセラノスティクス，インコーポレイティド filed Critical バイオセラノスティクス，インコーポレイティド
Publication of JP2010538609A publication Critical patent/JP2010538609A/ja
Publication of JP2010538609A5 publication Critical patent/JP2010538609A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2010524215A 2007-09-06 2008-09-06 腫瘍グレード分類と癌の予後診断 Pending JP2010538609A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97052907P 2007-09-06 2007-09-06
PCT/US2008/075528 WO2009108215A1 (en) 2007-09-06 2008-09-06 Tumor grading and cancer prognosis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014187715A Division JP2015057055A (ja) 2007-09-06 2014-09-16 腫瘍グレード分類と癌の予後診断

Publications (2)

Publication Number Publication Date
JP2010538609A true JP2010538609A (ja) 2010-12-16
JP2010538609A5 JP2010538609A5 (enExample) 2011-10-27

Family

ID=40790735

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010524215A Pending JP2010538609A (ja) 2007-09-06 2008-09-06 腫瘍グレード分類と癌の予後診断
JP2014187715A Pending JP2015057055A (ja) 2007-09-06 2014-09-16 腫瘍グレード分類と癌の予後診断

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014187715A Pending JP2015057055A (ja) 2007-09-06 2014-09-16 腫瘍グレード分類と癌の予後診断

Country Status (7)

Country Link
US (3) US9447470B2 (enExample)
EP (1) EP2195467B1 (enExample)
JP (2) JP2010538609A (enExample)
CN (1) CN102395682B (enExample)
CA (1) CA2698569A1 (enExample)
ES (1) ES2618353T3 (enExample)
WO (1) WO2009108215A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016537010A (ja) * 2013-09-09 2016-12-01 ブリティッシュ コロンビア キャンサー エージェンシー ブランチ 予後を予測するための方法及びキット、並びに、放射線照射療法を用いた乳癌の治療方法及びキット
KR20210034363A (ko) * 2019-09-20 2021-03-30 고려대학교 산학협력단 유방암 초음파 영상과 유전자 정보를 이용한 유방암 치료법 선택을 위한 정보를 제공하는 방법

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030198972A1 (en) 2001-12-21 2003-10-23 Erlander Mark G. Grading of breast cancer
US9856533B2 (en) 2003-09-19 2018-01-02 Biotheranostics, Inc. Predicting breast cancer treatment outcome
DK1899484T3 (da) * 2005-06-03 2015-11-23 Biotheranostics Inc Identifikation af tumorer og væv
WO2010151731A1 (en) * 2009-06-26 2010-12-29 University Of Utah Research Foundation Materials and methods for the identification of drug-resistant cancers and treatment of same
EP2648762B1 (en) * 2010-12-09 2018-02-21 Biotheranostics, Inc. Post-treatment breast cancer prognosis
US20120271553A1 (en) * 2011-04-22 2012-10-25 Ge Global Research Analyzing the expression of biomarkers in cells with clusters
US9470693B2 (en) 2012-05-18 2016-10-18 University Of North Dakota Method for quantifying proteins and isoforms thereof
IN2014MN02418A (enExample) * 2012-05-22 2015-08-14 Nanostring Technologies Inc
WO2013190081A1 (en) * 2012-06-22 2013-12-27 Proyecto De Biomedicina Cima, S.L. Methods and reagents for the prognosis of cancer
WO2015038682A1 (en) * 2013-09-11 2015-03-19 bio Theranostics, Inc. Predicting breast cancer recurrence
US10253369B2 (en) 2014-05-29 2019-04-09 Biotheranostics, Inc. Predicting likelihood of response to combination therapy
MX2018005867A (es) 2015-11-13 2018-09-21 Biotheranostics Inc Integracion de las caracteristicas tumorales con el indice de cancer de mama.
CN107119055A (zh) * 2017-05-18 2017-09-01 南京中医药大学 分子标志物bub1b基因及其应用
CN110021433B (zh) * 2017-08-30 2023-11-17 中山大学 一种用于精准预测胃肠胰神经内分泌肿瘤患者预后的系统
CN113490850B (zh) * 2018-08-17 2024-12-06 基因泰克公司 用于治疗乳腺癌的诊断和治疗方法
CN109706160A (zh) * 2019-02-22 2019-05-03 广西医科大学 重组人蛋白激酶Nek2蛋白表达和纯化方法
KR102508210B1 (ko) * 2020-10-16 2023-03-10 고려대학교 산학협력단 유방암 초음파 영상을 이용한 dna 유전자 정보를 제공하는 방법
CN115029437A (zh) * 2022-04-28 2022-09-09 深圳市陆为生物技术有限公司 检测样本中生物标志物的试剂在制备乳腺癌患者化疗响应评估产品中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006119593A1 (en) * 2005-05-13 2006-11-16 Universite Libre De Bruxelles Gene-based algorithmic cancer prognosis
JP2007505630A (ja) * 2003-09-19 2007-03-15 アビアラデックス，インコーポレイティド 乳がん治療転帰の予測

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545522A (en) 1989-09-22 1996-08-13 Van Gelder; Russell N. Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
WO2000029044A2 (en) 1998-11-13 2000-05-25 Pro Duct Health, Inc. Devices and methods to identify ductal orifices during nipple aspiration
US20030228575A1 (en) * 2001-01-31 2003-12-11 Yuk Ming Dennis Lo Combination of circulating epstein-barr virus (EBV) DNA in the serum or plasma of patients and a method to assess EBV subtypes for the prediction and detection of epstein-barr virus associated cancers
US20030064385A1 (en) * 2001-05-16 2003-04-03 Dressman Marlene Michelle Genes expressed in breast cancer as prognostic and therapeutic targets
US20030138793A1 (en) * 2001-06-10 2003-07-24 Irm Llc, A Delaware Limited Liability Company Molecular signatures of commonly fatal carcinomas
US20030198972A1 (en) * 2001-12-21 2003-10-23 Erlander Mark G. Grading of breast cancer
WO2005039382A2 (en) * 2003-06-24 2005-05-06 Genomic Health Prediction of likelihood of cancer recurrence
EP1644858B1 (en) * 2003-07-10 2017-12-06 Genomic Health, Inc. Expression profile algorithm and test for cancer prognosis
BRPI0414446A (pt) * 2003-09-18 2006-11-14 Genmab As métodos para triar um agente terapêutico, para a supressão da sequência de polinucleotìdeo, para o tratamento de um cáncer não dependente de esteróide, para triar a ligação de um agente especificamente a um polinucleotìdeo e para determinar se um paciente está em risco de desenvolver ou ter um cáncer não dependente de esteróide, composição farmacêutica, usos de um agente terapêutico, de uma molécula anti-sentido ou de uma célula que expressa e/ou contém a molécula anti-sentido, de pelo menos uma das proteìnas de membrana imunogênicas, fragmentos, derivados ou homólogos destas ou de uma célula que contém e/ou que expressa pelo menos uma das proteìnas de membranas imunogênicas ou fragmentos, derivados ou homólogos destas e de um agente ou anticorpo, agente, e, kit para identificar um paciente em risco de desenvolver ou ter cáncer não dependente de esteróide
US9856533B2 (en) 2003-09-19 2018-01-02 Biotheranostics, Inc. Predicting breast cancer treatment outcome
US7504214B2 (en) 2003-09-19 2009-03-17 Biotheranostics, Inc. Predicting outcome with tamoxifen in breast cancer
US7498693B2 (en) 2004-02-18 2009-03-03 Diversified Technologies, Inc. More compact and higher reliability power source system
DK1899484T3 (da) * 2005-06-03 2015-11-23 Biotheranostics Inc Identifikation af tumorer og væv

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007505630A (ja) * 2003-09-19 2007-03-15 アビアラデックス，インコーポレイティド 乳がん治療転帰の予測
WO2006119593A1 (en) * 2005-05-13 2006-11-16 Universite Libre De Bruxelles Gene-based algorithmic cancer prognosis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6013034531; Ｂｉｂｏ　Ｙｕａｎ　ｅｔ　ａｌ．: 'Ｉｎｃｒｅａｓｅｄ　Ｅｘｐｒｅｓｓｉｏｎ　ｏｆ　Ｍｉｔｏｔｉｃ　Ｃｈｅｃｋｐｏｉｎｔ　Ｇｅｎｅｓ　ｉｎ　Ｂｒｅａｓｔ　Ｃａｎｃｅｒ　Ｃｅｌｌｓ　ｗｉｔｈ　Ｃｈｒｏｍｏｓｏｍａｌ　Ｉｎｓｔａｂｉｌｉｔｙ' Ｃｌｉｎｉｃａｌ　Ｃａｎｃｅｒ　Ｒｅｓｅａｒｃｈ Ｖｏｌ．１２，　Ｎｏ．２, 20060115, 第４０５-４１０頁 *
JPN6013034533; Ｙａｍａｍｏｔｏ，　Ｙ．　ｅｔ　ａｌ．: 'Ｏｖｅｒｅｘｐｒｅｓｓｉｏｎ　ｏｆ　ＢＵＢＲ１　ｉｓ　ａｓｓｏｃｉａｔｅｄ　ｗｉｔｈ　ｃｈｒｏｍｏｓｏｍａｌ　ｉｎｓｔａｂｉｌｉｔｙ　ｉｎ　ｂｌａｄｄｅｒ　ｃａｎｃｅｒ' Ｃａｎｃｅｒ　Ｇｅｎｅｔｉｃｓ　ａｎｄ　Ｃｙｔｏｇｅｎｅｔｉｃｓ Ｖｏｌ．１７４，　Ｎｏ．１, 20070313, 第４２-４７頁 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016537010A (ja) * 2013-09-09 2016-12-01 ブリティッシュ コロンビア キャンサー エージェンシー ブランチ 予後を予測するための方法及びキット、並びに、放射線照射療法を用いた乳癌の治療方法及びキット
KR20210034363A (ko) * 2019-09-20 2021-03-30 고려대학교 산학협력단 유방암 초음파 영상과 유전자 정보를 이용한 유방암 치료법 선택을 위한 정보를 제공하는 방법
WO2021054752A3 (ko) * 2019-09-20 2021-07-22 고려대학교 산학협력단 유방암 초음파 영상과 유전자 정보를 이용한 유방암 치료법 선택을 위한 정보를 제공하는 방법
KR102405973B1 (ko) 2019-09-20 2022-06-07 고려대학교 산학협력단 유방암 초음파 영상과 유전자 정보를 이용한 유방암 치료법 선택을 위한 정보를 제공하는 방법
US12329583B2 (en) 2019-09-20 2025-06-17 Korea University Research And Business Foundation Method for providing information for choosing breast cancer treatment method by using breast cancer ultrasonic image and gene information

Also Published As

Publication number Publication date
JP2015057055A (ja) 2015-03-26
EP2195467A1 (en) 2010-06-16
US20180291461A1 (en) 2018-10-11
CN102395682B (zh) 2015-09-30
US9447470B2 (en) 2016-09-20
US20210371934A1 (en) 2021-12-02
US12492432B2 (en) 2025-12-09
EP2195467B1 (en) 2016-12-14
US20110136680A1 (en) 2011-06-09
WO2009108215A1 (en) 2009-09-03
CN102395682A (zh) 2012-03-28
CA2698569A1 (en) 2009-09-03
US11021754B2 (en) 2021-06-01
ES2618353T3 (es) 2017-06-21

Similar Documents

Publication Publication Date Title
US12492432B2 (en) Tumor grading and cancer prognosis
US12460265B2 (en) Post-treatment breast cancer prognosis
CN101356532B (zh) 基于基因的算法型癌症预后
US20220186317A1 (en) Predicting breast cancer recurrence
EP2121988B1 (en) Prostate cancer survival and recurrence
AU2016263590A1 (en) Methods and compositions for diagnosing or detecting lung cancers
CN107614696A (zh) 基因表现图谱以及将其应用于乳癌医疗之方法
US10253369B2 (en) Predicting likelihood of response to combination therapy
US20180051342A1 (en) Prostate cancer survival and recurrence
HK1197803A (en) Post-treatment breast cancer prognosis
AU2014318859A1 (en) Predicting breast cancer recurrence
HK1127413A (en) Gene-based algorithmic cancer prognosis

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110906

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110906

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130716

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131015

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131022

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140513

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20140812

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140916

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20140925

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20141107